134 related articles for article (PubMed ID: 37919620)
21. Prognosis of untreated patients with idiopathic membranous nephropathy.
Schieppati A; Mosconi L; Perna A; Mecca G; Bertani T; Garattini S; Remuzzi G
N Engl J Med; 1993 Jul; 329(2):85-9. PubMed ID: 8510707
[TBL] [Abstract][Full Text] [Related]
22. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?
Philibert D; Cattran D
Nat Clin Pract Nephrol; 2008 Oct; 4(10):550-9. PubMed ID: 18725916
[TBL] [Abstract][Full Text] [Related]
23. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
24. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
25. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
Yang S; Xie L; Xue W; Yin A; Lu W
Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
[TBL] [Abstract][Full Text] [Related]
26. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
[TBL] [Abstract][Full Text] [Related]
27. Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria.
Sun J; Li M; Zhu Q; Jia Y; Tian J; Zhang C; Du X
Ren Fail; 2023 Dec; 45(1):2188088. PubMed ID: 36967636
[TBL] [Abstract][Full Text] [Related]
28. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
29. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy.
Zietse R; Derkx FH; Schalekamp MA; Weimar W
Contrib Nephrol; 1995; 114():6-18. PubMed ID: 7587200
[No Abstract] [Full Text] [Related]
31. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
Arai H; Toda N; Kamimatsuse R; Nishioka K; Endo S; Akiyama S; Maruyama S; Matsubara T; Yokoi H; Yanagita M
Intern Med; 2018 Oct; 57(19):2873-2877. PubMed ID: 29709946
[TBL] [Abstract][Full Text] [Related]
32. Serum lipoprotein (a) in men with proteinuria due to idiopathic membranous nephropathy.
Short CD; Durrington PN; Mallick NP; Bhatnagar D; Hunt LP; MBewu A
Nephrol Dial Transplant; 1992; 7 Suppl 1():109-13. PubMed ID: 1337176
[TBL] [Abstract][Full Text] [Related]
33. Membranous nephropathy in a 13-year-old boy with common variable immunodeficiency.
Yim HE; Yoo KH
J Korean Med Sci; 2012 Nov; 27(11):1436-8. PubMed ID: 23166431
[TBL] [Abstract][Full Text] [Related]
34. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; Pisano L; D'Amico G
Am J Kidney Dis; 2001 Aug; 38(2):240-8. PubMed ID: 11479148
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
36. Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.
Timmermans SA; Abdul Hamid MA; Cohen Tervaert JW; Damoiseaux JG; van Paassen P;
Am J Nephrol; 2015; 42(1):70-7. PubMed ID: 26344651
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
[TBL] [Abstract][Full Text] [Related]
38. Membranous Nephropathy: Quantifying Remission Duration on Outcome.
Cattran DC; Kim ED; Reich H; Hladunewich M; Kim SJ;
J Am Soc Nephrol; 2017 Mar; 28(3):995-1003. PubMed ID: 27756808
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Matsumoto Y; Shimada Y; Nojima Y; Moriki T
Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
[TBL] [Abstract][Full Text] [Related]
40. Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.
Xu C; Xu T; Liu N; Liu L; Sun L; Li X; Li Z; Yao L
Int Urol Nephrol; 2024 Feb; 56(2):699-706. PubMed ID: 37480482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]